Named after the hundred-eyed watchman of Greek myth, Argus watches the education landscape: spotting new opportunities, pressure-testing the ventures we're building, and tracing every read back to the real-world signals behind it.
The evidence library: the raw signals the pipeline is watching across the education ecosystem. Every idea is built from these.
CMS unveiled new details of its new RAPID pathway, which is designed to close the gap between FDA approval and Medicare coverage for breakthrough medical devices. Industry reaction has been largely positive, as medical device companies often sit in “coverage purgatory” for years. The post How CMS Is Tackling ‘Coverage Purgatory’ for Medical Devices appeared first on MedCity News .
Tanvi Patel, vice president and general manager of Amazon Pharmacy, and her co-panelists at the recent Bullseye event, explained why PBMs, payers and doctors are all hampering consumer choice when it comes to patients getting affordable drugs. The post Amazon Pharmacy Executive: Formularies are Anti-Choice appeared first on MedCity News .
Small group insurers are proposing a median 14% premium increase for 2027, driven by rising healthcare costs. The post Small Businesses Could Face Double-Digit Premium Hikes in 2027 appeared first on MedCity News .
Jazz Pharmaceuticals, maker of the blockbuster epilepsy drug Epidiolex, is acquiring Actio Biosciences and its lead drug in pivotal testing for a rare type of epilepsy with no FDA-approved treatments. It’s Jazz’s second epilepsy deal in the past year. The post Jazz Pharma Expands Again in Epilepsy With $820M Actio Bio Acquisition appeared first on MedCity News .
In this episode of the MedCity Pivot Podcast, CVS Health Aetna’s chief digital and technology officer talks about how the insurance business is using AI, especially agentic AI, in healthcare. Point to note: AI is not used in automatic denials of coverage. The post MedCity Pivot: How Aetna is Adopting Agentic AI appeared first on MedCity News .
Drug development isn’t limited by the amount of data we collect, but by our ability to preserve the context, meaning and relationships that transform data into evidence. The post AI in Drug Development is Not a Data Problem — It’s An Evidence Problem appeared first on MedCity News .
Ascension is pushing AI beyond note-taking to tackle the billing, order entry and nursing handoff work still weighing on clinicians after a patient visit ends. The post How to Keep Clinicians Satisfied, the Ascension Way appeared first on MedCity News .
[Sponsored] With home health fraud growing more sophisticated through AI, post-pay audits are no longer enough. Payers must shift to proactive, tech-driven prevention to catch improper claims before paying them. The post Compliance Alone Won’t Fix the Home Health Fraud Problem appeared first on MedCity News .
In addition to pricing the biggest biotech IPO of the week, Braveheart Bio’s underwriters exercised their option to purchase more shares, boosting the clinical-stage company’s total haul to nearly $440 million. Braveheart’s lead drug could be competitive with a blockbuster Bristol Myers Squibb medicine for a type of cardiomyopathy. The post Braveheart Bio’s $382M IPO for Heart Drug Leads a Big Week for Biotech IPOs appeared first on MedCity News .
In this episode, we’re joined by Cheryl Larson, president and CEO of the Midwest Business Group on Health, for our first in-person recording at MedCity News’ recent Bullseye event. The post MedCity FemFwd: Employer Strategies for Women’s Health appeared first on MedCity News .
Hinge Health’s acquisition of Cylinder expands it into GI care, but experts differ on whether employers will favor convenience or specialized solutions. The post Two Differing POVs Emerge About the Hinge-Cylinder Deal appeared first on MedCity News .
HHS is reviving a rebate program for 340B drug discounts after the previous pilot was blocked in court earlier this year. Providers say the change will burden already cash-strapped providers with new administrative and financial costs. The post HHS Is Reviving Its 340B Rebate Push — And Providers Are None Too Pleased appeared first on MedCity News .
An Elevance Health Public Policy Institute study found rural patients used telehealth less than non-rural patients across all chronic conditions and insurance types. The post Report: Telehealth Uptake Is Lagging in Rural Areas appeared first on MedCity News .
M&A activity is going beyond big pharma acquisitions with Supernus Pharmaceuticals and Indivior Pharmaceuticals reaching a stock deal that the companies call a merger of equals. The combined company’s portfolio will have 11 commercialized products in addiction, attention-deficit hyperactivity disorder, depression, and Parkinson’s disease. The post Supernus and Indivior to Merge, Forming a New CNS-Focused Pharma Company appeared first on MedCity News .
Ethical AI and trustworthy AI frameworks should be table stakes for healthcare and life sciences organizations seeking to innovate with AI. The post From Ethics to Trust: Strategic Guardrails for Safe, Secure, Effective AI in Healthcare appeared first on MedCity News .
The products that succeed over time are usually the ones that make life easier, fit naturally into existing routines and continue delivering value long after the novelty wears off. The post Beyond Adoption: The Habits Shaping Digital Health appeared first on MedCity News .
Sentara Health notified Anthem that it will let its commercial, Medicare and Medicaid contracts expire at year’s end unless the two sides reach a new rate agreement. The dispute puts coverage for an estimated 380,000 Virginians at risk. The post ‘We’re Not Going to Be Bullied’: Sentara Digs in on Anthem Contract Fight appeared first on MedCity News .
July has seen a slew of executive hires, exits and layoffs across the healthcare industry. For instance, Aledade, Providence and Whoop named new executives. There were also layoffs at organizations including Novartis, Adventist Health and Wellstar Health System. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity News .
Grove AI’s technology uses voice agents to recruit eligible patients for clinical trials. Formed in 2024, the startup’s rapid growth led to its acquisition by Hippocratic AI earlier this year. The post Startup to Acquisition in 2 Years: Grove AI’s Journey to Transform Clinical Trials appeared first on MedCity News .
Daffodil Health launched an AI-powered solution to help payers manage No Surprises Act disputes by automating claims review, negotiations and arbitration workflows. The post Daffodil Health Launches No Surprises Act Dispute Management Solution appeared first on MedCity News .
Caring for patients with ADHD, or those who potentially have ADHD, extends far beyond diagnosis and prescribing. The post The Battles We Face: ADHD From A Patient Perspective, And What Providers Should Know appeared first on MedCity News .
What healthcare needs now is a connected, deeply integrated system of action that works with the system of record to complete work across the enterprise, supported by accountable partners willing to stand behind the outcomes they create. The post Three Ways Distressed Healthcare Must Evolve appeared first on MedCity News .
Function Health raised $450 million in growth financing from General Catalyst’s Customer Value Fund, just eight months after its $298 million Series B. The lab-testing startup plans to use the capital to expand access to its testing and imaging services. The post Why General Catalyst Is Betting $450M on Function Health’s Preventive Care Push appeared first on MedCity News .
More than a dozen health systems are warning patients of a phishing campaign impersonating Epic’s MyChart portal with fake Medicare rewards and faux login pages. Experts say the scam exposes a deeper problem: patients can’t be expected to spot increasingly polished fakes, so the responsibility falls on providers to communicate in ways that build trust. The post Epic MyChart Phishing Scam Hits Health Systems: What Providers Should Do appeared first on MedCity News .
Roivant Sciences subsidiary Priovant Therapeutics received FDA approval for Lisraya as a treatment for the rare inflammatory disorder dermatomyositis. Licensed from Pfizer, this once-daily pill designed to block JAK1 and TYK2 proteins is also in clinical development for three additional rare immunological disorders, each with blockbuster potential. The post FDA Nod for Inflammation Drug Notches Wins for Rare Disease Patients, Roivant’s Biz Strategy appeared first on MedCity News .
Chronic wounds demand clinicians willing to act outside of their defined role, not because the system incentivizes it, but because without it, the wound will not heal. The post The Silent Epidemic: Why Diabetic Foot Ulcers Have Been Overlooked for Three Decades appeared first on MedCity News .
We are on the cusp of an age of anticipatory medicine, an explosion in our ability to read the body’s signals and catch the killers before they do their damage. The post Reading the Body’s Signals: AI’s Ultimate Healthcare Opportunity appeared first on MedCity News .
Priority Health partnered with Color Health and Grail to offer self-funded employers virtual cancer navigation, support and multi-cancer early detection beginning in 2027. The post Priority Health Launches 2 Cancer Support Solutions with Color Health, Grail appeared first on MedCity News .
We’re about to enter a world beyond just talking to a chat tool about your health. AI tools are on the precipice of being able to take action on their advice. The post AI Will Reshape the Patient Experience appeared first on MedCity News .
The question is no longer whether healthcare innovation is accelerating. The question is where investors gain access to generate the strongest returns. The post Healthcare’s Next Source of Alpha Is Moving Upstream appeared first on MedCity News .
Scribe Therapeutics’ IPO will support a pipeline led by a genetic medicine that represses expression of its target gene without making permanent changes. Common chronic cardiometabolic conditions are Scribe’s initial focus as the biotech works to bring genetic medicines beyond rare diseases. The post CRISPR Biotech Scribe Therapeutics Writes a New Chapter With $129M IPO appeared first on MedCity News .
Unlike past healthcare tech waves sold on cost savings, AI is proving it can generate new revenue — with returns as high as 100x, according to a panel of investors at MedCity News’ Bullseye event. The post Healthcare Investors Are Rewriting the ROI Playbook from Cost-Cutting to Cash Flow appeared first on MedCity News .
Along with Ambros Therapeutics’ merger with Werewolf Therapeutics, the combined company will raise $150 million in a private placement. Ambros is in Phase 3 testing with a drug developed for treating a type of pain that does not respond to currently available medicines, including opioids. The post Ambros Therapeutics’ Path for Pain Drug Goes Through Reverse Merger With Werewolf appeared first on MedCity News .
Today, 3D modeling and printing technology can make a dramatic impact — even shortening some operations by 30-90 minutes. Looking ahead, that reduction will only grow as the technology is further integrated and becomes more advanced. The post The Pulse of Innovation: How 3D Models Can Prepare Surgeons for the Operating Room appeared first on MedCity News .
Gaps in reimbursement oversight and recovery will only widen, unless plans modernize how they detect, investigate, and recoup improper payments. The post Modernizing Payment Integrity in an Era of Systemic Fraud appeared first on MedCity News .
Juno Bio’s funding was supported by Ada Ventures, Artesian, Entrepreneur First and Illumina Accelerator. The post Juno Bio Raises $3.8M to Support Vaginal Health appeared first on MedCity News .
HSS chief digital and information officer Ashis Barad, who has worked on both the payer and provider sides of healthcare AI, thinks the industry’s growing “bot vs. bot” battle over prior authorizations and appeals is driving costs up. To him, the real fix lies in providers and payers sharing data to build more personalized care pathways. The post The ‘Bot Vs. Bot’ Dynamic Between Providers & Payers Is Driving Up Costs for Everyone appeared first on MedCity News .
GSK said the mixed Phase 3 results for camlipixant mean this pill “is unlikely to transform patient care” in recurrent chronic cough. GSK is stopping work in this indication, a setback to a program once hoped to yield a new blockbuster product for the company’s respiratory drug portfolio. The post GSK Drug From $2B Deal Sputters in Phase 3 Test in Chronic Cough appeared first on MedCity News .
The opportunity ahead is to treat physician well-being as a core strategic priority, measured with the same rigor and acted upon with the same urgency as any other critical performance domain. The post Why Specialty-Specific Measurement and Intervention Are Essential to Address Healthcare Burnout appeared first on MedCity News .
PatientRightsAdvocate.org sued the American Medical Association this week, arguing the trade group has no valid copyright over the CPT codes that providers must use to bill for care. It follows a public letter Senator Bill Cassidy sent to the AMA last year accusing it of “abus[ing] [its] government-backed monopoly by charging exorbitant fees to anyone using the CPT code set.” The post Patient Group Sues AMA, Says the Org Shouldn’t Be Charging for CPT Codes appeared first on MedCity News .
Venrock led Aligned Marketplace’s Series A round. In total, the company has raised $31 million to date. The post Aligned Marketplace Secures $20M for Advanced Primary Care Marketplace appeared first on MedCity News .
Bristol Myers Squibb’s Zenbexus is the first FDA-approved drug in a new class of cancer drugs called CELMoDs. The pharma company is positioning this molecule as a successor to its legacy products for multiple myeloma. The post Bristol Myers Squibb Protein Degrader Wins First-in-Class FDA Nod in Multiple Myeloma appeared first on MedCity News .
Most younger professionals entering the workforce have little visibility into interoperability, digital health infrastructure, or healthcare data architecture as career pathways. The post Healthcare Keeps Buying AI. But Nobody’s Building the Workforce to Run It. appeared first on MedCity News .
A bipartisan group of six senators introduced a bill to reform the 340B drug program, locking in hospitals’ use of contract pharmacies and adding new transparency and compliance rules. The legislation would also kill HHS’ contested rebate pilot within a year and replace it with a national data clearinghouse to catch duplicate discounts. The post Bipartisan Lawmakers Are Fighting HHS’ 340B Rebate Push appeared first on MedCity News .
Replimune went from an FDA rejection to a resubmission, a positive advisory committee vote, and finally an accelerated regulatory approval for advanced melanoma — all in less than four months. The FDA nod for Replimune’s oncolytic viral therapy, Tudriqev, positions it as a more convenient alternative to an Iovance Biotherapeutics cell therapy that had been the only treatment in this setting. The post Recovery for Replimune: Accelerated Approval for Cancer Drug Twice Spurned by FDA appeared first on MedCity News .
Democratic senators are urging CMS to withdraw its Medicaid work requirements rule, arguing it will create administrative burdens and cause eligible beneficiaries to lose coverage. The post Democratic Senators Urge Withdrawal of Interim Final Rule on Medicaid Work Requirements appeared first on MedCity News .
Historically, prevention has focused on protecting teeth from decay and gum disease. However, long-term oral health is also shaped by how the teeth, muscles, and jaw function together over time. The post The Missing Piece of Preventive Dental Care Lies in the Bite appeared first on MedCity News .
Gaps in prevention are not frequently due to a complete lack of information, but instead the fact that organizations don’t have a clear way to see how the pieces fit together until after an incident has occurred. The post Healthcare Workplace Violence Prevention Needs Better Visibility Into Risk Signals appeared first on MedCity News .
Scheduled for October 29 at Pegasus Park in Dallas, the theme of the INVEST Digital Health conference will be consumers in healthcare from d2c diagnostics to GLP-1 drugs and wearables. Register today! The post INVEST Digital Health Conference Returns with Focus on Consumers appeared first on MedCity News .